Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-04
2007-09-04
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S254000
Reexamination Certificate
active
11240801
ABSTRACT:
The invention provides new forms of a chemical compound of formula (I). The invention relates to forms of a chemical compound (I), in particular to crystalline and amorphous forms, more particularly four crystalline forms and an amorphous form. The invention further relates to processes for the preparation of such forms, to pharmaceutical compositions comprising the compound in crystalline and/or amorphous form and to therapeutic use of such forms.
REFERENCES:
patent: 6525060 (2003-02-01), Hardern et al.
patent: 6713483 (2004-03-01), Guile et al.
patent: 2003/0148888 (2003-08-01), Larsson et al.
patent: 2006/0025590 (2006-02-01), Hardern et al.
patent: 9905143 (1999-02-01), None
patent: 0034283 (2000-06-01), None
Bohlin Martin
Cosgrove Steve
Lassen Bo
AstraZeneca AB
Berch Mark L.
Nixon & Vanderhye
LandOfFree
Cristalline and amorphous form of a triazolo (4,5-D)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cristalline and amorphous form of a triazolo (4,5-D)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cristalline and amorphous form of a triazolo (4,5-D)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3798752